Using pegylated arginine deiminase (ADI-PEG20) for the treatment of sarcomas that lack argininosuccinate synthesase 1 expression.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Brian Andrew Van Tine, Gregory R Bean, Phillip Boone, Munir Tanas, Matthew B Schulze, David Y Chen, John S. Bomalaski, Brian Rubin
Institutions: Washington University in St. Louis, Cleveland Clinic
Language: English
Topic: Bacterial Cancer Therapy
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2965171919